(E)-9-[(2-fluoromethyl-2-hydroxymethylcyclopropylidene)methyl]adenine | 1026675-97-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: (E)-9-[(2-fluoromethyl-2-hydroxymethylcyclopropylidene)methyl]adenine
• 英文别名: [(2E)-2-[(6-aminopurin-9-yl)methylidene]-1-(fluoromethyl)cyclopropyl]methanol
• CAS: 1026675-97-7
• 化学式: C₁₁H₁₂FN₅O
• 分子量: 249.248
• InChiKey: RVJJMCCKPKGPMS-FARCUNLSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  89.8
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (Z,E)-9-[(2-acetoxymethyl-1-fluoromethylcyclopropylidene)methyl]adenine 在 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 1.0h， 以49%的产率得到(Z)-9-[(2-fluoromethyl-2-hydroxymethylcyclopropylidene)methyl]adenine
  参考文献：
  名称：

  Fluorinated methylenecyclopropane analogues of nucleosides. Synthesis and antiviral activity of (Z)- and (E)-9-{[(2-fluoromethyl-2-hydroxymethyl)-cyclopropylidene]methyl}adenine and -guanine

  摘要：

  Synthesis and antiviral activity of the title fluoromethylenecyclopropane analogues 15a, 15b, 16a, and 16b is described. Methylenecyclopropane carboxylate was first transformed to 2,2-bis-hydroxymethylmethylenecyclopropane. Selective monoacetylation followed by introduction of fluorine gave 2-acetoxymethyl-2-fluoromethylmethylenecyclopropane as the key inter-mediate. The synthesis of analogues 15a, 15b, 16a, and 16b then followed alkylation-elimination procedure as described previously for other methylenecyclopropane analogues. The adenine Z-isomer 15a was found to be a potent inhibitor of Epstein-Barr virus (EBV) in vitro with EC50/CC50 (mu M) 0.5/55.7. Compounds 15b, 16a, and 16b were also active but at higher concentrations, EC50/CC50 (mu M) 3.2-7.5/53.6-64.1. Analogue 15a inhibited hepatitis C virus by virtue of its cytotoxicity and it moderately inhibited replication of the Towne strain of human cytomegalovirus (HCMV). The E-isomer 16a was a substrate for adenosine deaminase, whereas the Z-isomer 15a was not deaminated. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2007.11.082